tolvaptan has been researched along with Acute Kidney Failure in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 7 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, M; Huang, X; Tang, C; Wang, D; Xu, C; Yan, G | 1 |
| Hosoda, S; Kitagataya, T; Kohya, R; Kubo, A; Morikawa, K; Nakai, M; Ogawa, K; Ohara, M; Sakamoto, N; Sasaki, T; Sho, T; Suda, G; Tokuchi, Y; Yamada, R; Yoshida, S | 1 |
| Hasegawa, M; Hayashi, H; Inaguma, D; Koide, S; Ogata, S; Tagaya, T; Takahashi, K; Tsuboi, N; Yuzawa, Y | 1 |
| Griffin, M; Konstam, MA; McCallum, W; Sarnak, MJ; Testani, JM; Tighiouart, H; Udelson, JE | 1 |
| Hiramine, Y; Hiwaki, T; Ido, A; Imamura, Y; Kanmura, S; Maenohara, S; Mawatari, S; Oku, M; Saishoji, A; Tokushige, K; Uto, H | 1 |
| Alukal, JJ; John, S; Thuluvath, PJ | 1 |
| Hirano, D; Ito, A; Kakegawa, D; Miwa, S; Takemasa, Y; Tokunaga, A; Umeda, C; Yuhei, K | 1 |
| Jolobe, OMP | 1 |
| Fang, CY; Fang, HY; Lee, WC | 1 |
| Hatano, M; Hosoya, Y; Imamura, T; Inaba, T; Kato, N; Kinugawa, K; Komuro, I; Kyo, S; Maki, H; Minatsuki, S; Muraoka, H; Ono, M; Shiga, T; Takahashi, M; Yao, A | 1 |
| Asai, K; Hata, N; Kobayashi, N; Matsushita, M; Okazaki, H; Shimizu, W; Shinada, T; Shirakabe, A; Tomita, K; Tsurumi, M; Yamamoto, M; Yamamoto, Y; Yokoyama, S | 1 |
| Dohi, K; Ito, M | 1 |
| Boertien, WE; Czerwiec, FS; de Jong, PE; Engels, GE; Gansevoort, RT; Kappert, P; Krasa, HB; Meijer, E; Oberdhan, D; Ouyang, J; Renken, RJ; Struck, J; ter Horst, GJ; van der Jagt, EJ; van Oeveren, W | 1 |
| Asada, Y; Kitamura, K; Nishihira, K; Okubo, T; Yamaguchi, M | 1 |
1 review(s) available for tolvaptan and Acute Kidney Failure
| Article | Year |
|---|---|
Hyponatremia in Cirrhosis: An Update.
Topics: Acute Kidney Injury; Acute-On-Chronic Liver Failure; Albumins; Antidiuretic Hormone Receptor Antagonists; Ascites; Fluid Therapy; Hepatic Encephalopathy; Hepatorenal Syndrome; Humans; Hypertension, Portal; Hyponatremia; Liver Cirrhosis; Liver Transplantation; Renin-Angiotensin System; Saline Solution, Hypertonic; Splanchnic Circulation; Tolvaptan; Vasodilation; Vasopressins | 2020 |
2 trial(s) available for tolvaptan and Acute Kidney Failure
| Article | Year |
|---|---|
Acute Kidney Function Declines in the Context of Decongestion in Acute Decompensated Heart Failure.
Topics: Acute Kidney Injury; Aged; Antidiuretic Hormone Receptor Antagonists; Biomarkers; Female; Glomerular Filtration Rate; Heart Failure; Humans; Kidney; Male; Middle Aged; Natriuretic Peptide, Brain; Prognosis; Stroke Volume; Tolvaptan | 2020 |
Immediate administration of tolvaptan prevents the exacerbation of acute kidney injury and improves the mid-term prognosis of patients with severely decompensated acute heart failure.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Disease-Free Survival; Female; Follow-Up Studies; Heart Failure; Hospital Mortality; Humans; Male; Prospective Studies; Survival Rate; Time Factors; Tolvaptan | 2014 |
11 other study(ies) available for tolvaptan and Acute Kidney Failure
| Article | Year |
|---|---|
Tolvaptan Improves Contrast-Induced Acute Kidney Injury.
Topics: Acute Kidney Injury; Animals; Apoptosis; Kidney; Male; Oxidative Stress; Rats; Rats, Wistar; Tolvaptan | 2022 |
Neutrophil gelatinase-associated lipocalin predicts the efficacy of tolvaptan for ascites in patients with liver cirrhosis.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Ascites; Biomarkers; C-Reactive Protein; Humans; Lipocalin-2; Lipocalins; Liver Cirrhosis; Proto-Oncogene Proteins; Tolvaptan; Water | 2023 |
Tolvaptan's Association with Low Risk of Acute Kidney Injury in Patients with Advanced Chronic Kidney Disease and Acute Decompensated Heart Failure.
Topics: Acute Disease; Acute Kidney Injury; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Furosemide; Heart Failure; Humans; Male; Renal Insufficiency, Chronic; Retrospective Studies; Tolvaptan | 2023 |
Impact of acute kidney injury on prognosis and the effect of tolvaptan in patients with hepatic ascites.
Topics: Acute Kidney Injury; Administration, Oral; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Ascites; Diuretics; Drug Therapy, Combination; Female; Humans; Incidence; Liver Cirrhosis; Male; Middle Aged; Prognosis; Propensity Score; Retrospective Studies; Survival Analysis; Tolvaptan; Treatment Outcome | 2021 |
Impact of acute kidney injury in patients prescribed angiotensin-converting enzyme inhibitors over the first two years of life.
Topics: Acute Kidney Injury; Angiotensin-Converting Enzyme Inhibitors; Child; Down Syndrome; Humans; Infant; Infant, Newborn; Male; Renal Insufficiency, Chronic; Retrospective Studies; Risk Factors; Tolvaptan | 2021 |
A diuretic-sparing strategy to facilitate deactivation of vasopressin secretion.
Topics: Acute Kidney Injury; Animals; Diuretics; Heart Failure; Humans; Rats, Wistar; Tolvaptan; Vasopressins | 2018 |
Tolvaptan rescue contrast-induced acute kidney injury: A case report.
Topics: Acute Kidney Injury; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Contrast Media; Coronary Artery Disease; Female; Humans; Hyponatremia; Middle Aged; Oliguria; Percutaneous Coronary Intervention; Tolvaptan | 2018 |
A case with recovery of response to tolvaptan associated with remission of acute kidney injury and increased urine osmolality.
Topics: Acute Kidney Injury; Adolescent; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Heart Failure; Humans; Osmolar Concentration; Tolvaptan | 2013 |
Immediate and short-term use of tolvaptan for acute decompensated heart failure.
Topics: Acute Kidney Injury; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Heart Failure; Humans; Male; Tolvaptan | 2014 |
Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function.
Topics: Acute Kidney Injury; Adult; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Biomarkers; Cohort Studies; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Glomerular Filtration Rate; Glycopeptides; Humans; Kidney; Magnetic Resonance Imaging; Male; Middle Aged; Organ Size; Osmolar Concentration; Polycystic Kidney, Autosomal Dominant; Prospective Studies; Renal Insufficiency, Chronic; Severity of Illness Index; Tolvaptan; Treatment Outcome | 2015 |
Acute Renal Injury Induced by Hypersensitivity to Tolvaptan in an Elderly Patient with Congestive Heart Failure.
Topics: Acute Kidney Injury; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Pressure; Drug Hypersensitivity; Female; Heart Failure; Humans; Receptors, Vasopressin; Tolvaptan | 2015 |